ClinicalTrialsFinder
RecruitingNot ApplicableNCT06062693

New Interactive Sensor-home-based Hand Training to Improve Dexterity

Sponsor

Luzerner Kantonsspital

Enrollment

160 participants

Start Date

Jun 1, 2023

Study Type

INTERVENTIONAL

Conditions

StrokeMultiple SclerosisParkinson Disease

Summary

Primary objective of this study is to explore the impact of a 3-week upper limb hand function training in patients with PD, MS or stroke. The benefits on hand function of this training program will be evaluated. The hypothesize is that the 3-week upper limb hand function training improves finger dexterity.

Eligibility

Min Age: 18 YearsMax Age: 99 Years

Inclusion Criteria9

  • Patients with confirmed PD, according to UK Brain bank Criteria (Hughes et al., 1992) or
  • MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria or
  • subacute stroke
  • written and signed informed consent
  • self-reported hand function problems
  • or
  • healthy subject
  • written and signed informed consent
  • no self-reported hand function problems

Exclusion Criteria4

  • MoCA \<21/30
  • psychiatric disease
  • participation on other interventional trials
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Interventions

DEVICEsmart sensor egg training

The portable hand trainer has three principal functionalities: (I) Grasping, (II) Pronosupination, and (III) wrist and finger extension. Different exercises can be done.

Locations(1)

Luzerner Kantonsspital

Lucerne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06062693

Related Trials

From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis

NCT048734921 location

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

NCT0447778550 locations

Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

NCT074776392 locations

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

NCT0381634552 locations

Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment

NCT067824641 location